Loading clinical trials...
Loading clinical trials...
The primary goal of the study is to evaluate an investigational drug's effectiveness as a treatment for Non small-cell lung cancer (NSCLC)
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Research Center
Berkeley, California, United States
Research Center
Greenbrae, California, United States
Research Center
Los Angeles, California, United States
Research Center
Rancho Mirage, California, United States
Research Center
Chicago, Illinois, United States
Research Center
Louisville, Kentucky, United States
Research Center
West Boylston, Massachusetts, United States
Research Center
Ann Arbor, Michigan, United States
Research Center
Lebanon, New Hampshire, United States
Research Center
Nashville, Tennessee, United States
Primary Completion Date
October 1, 2002
Completion Date
October 1, 2002
Last Updated
February 16, 2012
Investigational drug
DRUG
Lead Sponsor
Pfizer
NCT06667908
NCT04165798
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06875310